Page 81 - Abt News Today

Signaturefd LLC raised its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.3% in the second quarter, Holdings Channel.com reports. The institutional investor owned 42,518 shares of the healthcare product maker’s stock after buying an additional 976 shares during the period. Signaturefd LLC’s holdings in Abbott Laboratories were worth $4,635,000 at the […]

Heritage Investors Management Corp decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 44,505 shares of the healthcare product maker’s stock after selling 750 shares during the period. Heritage Investors Management Corp’s holdings […]

Ten Capital Wealth Advisors LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 23.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,545 shares of the healthcare product maker’s stock after acquiring an additional 491 shares during the period. Ten […]

Schulhoff & Co. Inc. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 28,371 shares of the healthcare product maker’s stock after selling 465 shares during the period. Abbott Laboratories makes up 1.4% […]

First Interstate Bank cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 28,613 shares of the healthcare product maker’s stock after selling 280 shares during the quarter. First Interstate Bank’s holdings in […]

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price objective decreased by research analysts at Morgan Stanley from $112.00 to $107.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “equal weight” rating on the healthcare product maker’s stock. Morgan Stanley’s target price indicates a potential upside of […]

Abbott Laboratories (NYSE:ABT – Get Free Report) updated its FY23 earnings guidance on Wednesday. The company provided earnings per share guidance of $4.42-4.46 for the period, compared to the consensus earnings per share estimate of $4.40. Abbott Laboratories also updated its FY 2023 guidance to $4.42-$4.46 EPS. Wall Street Analyst Weigh In Several analysts have […]

Fiduciary Trust Co. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.8% during the second quarter, Holdings Channel.com reports. The institutional investor owned 317,068 shares of the healthcare product maker’s stock after selling 2,566 shares during the period. Fiduciary Trust Co.’s holdings in Abbott Laboratories were worth $34,567,000 at the end of […]

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target lowered by investment analysts at Raymond James from $123.00 to $110.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the healthcare product maker’s stock. Raymond James’ price objective would suggest a potential upside of 14.63% […]

Mechanics Financial Corp increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 26.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,183 shares of the healthcare product maker’s stock after acquiring an additional 1,308 shares during […]